, the clinical effects remain controversial. The most plausible reason for inconsistent results in previous studies could possibly be attributed to the small sample size, probably because a number of participants had issues in completing the CR programs. For instance, HF-ACTION, the largest multicenter randomized controlled trial investigating the efficacy and safety of CR in patients with chronic heart failure 5) , could not reveal any significant reduction in the risk for all-cause mortality or all-cause hospitalization, which was explained by the low rate (only 30%) of the patients who accomplished the target exercise training. Another possible explanation for the discordance is that the methods of exercise training in previous studies were different. Because the mode of exercise, intensity, duration, and frequency were not standardized in the previous research, it is not appropriate to compare the clinical outcomes. Thus, an optimal and unified method for CR should be developed.
In this issue of the Journal of Atherosclerosis and Thrombosis, Furuyama et al. investigated the effect of CR on the cholesterol efflux capacity (CEC) of HDL 3) . They showed that a five-month outpatient CR of the patients with acute coronary syndrome improved the CEC without a significant change in the plasma HDL-C level. The increase in the CEC was correlated with that of the anti-oxidative arylesterase activity (AREA), whereas the correlations with other biomarkers were considerably different between the CEC and AREA. The rate of change in apoA-I had higher correlation with that in the CEC and AREA than that in HDL-C.
Although this study is a single-center retrospective analysis based on a relatively small sample size, it has a potential clinical significance because it first demonstrated the beneficial effects of CR on both the CEC and AREA in CAD patients, irrespective of the use of statins. The CR program was appropriately conducted in accordance with the Japanese Circulation Society guidelines 1) with a high achievement rate (87%) of CR 3) , which could have considerably influenced the HDL function. Although the correlation between peak VO2 and the CEC was not significant, there was a marked association between peak VO2 and the AREA. Thus, CR might have ameliorating effects, mainly by enhancing the paraoxonase1 (PON1) enzymatic activity and the apoA-I expression. PON1 protects various components in the HDL particles from oxidative modification, which may result in an improvement in the CEC.
The molecular mechanisms of PON 1 activation by exercise training have not yet been clarified. It has been reported that physical exercises induce various types of myokines in skeletal muscles, such as IL-6, cises appear as one of the most promising regulators for the HDL function because they have multiple pleiotropic effects not only on atherosclerosis but also on the prevention of cancer, osteoporosis, mental disorder, and cognitive function. In addition, exercises are highly cost effective. Given the increasing importance of CR in CAD, it is greatly desired that the large multi-centered trial with standardized CR protocol and high achievement rate will explore the effectiveness of CR on the prognosis of cardiovascular diseases in the near future.
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